Lisa J Zimmerman

Lisa J Zimmerman is an accomplished inventor based in Franklin, TN (US). She has made significant contributions to the field of cancer diagnostics through her innovative research and patented technologies. With a total of 2 patents, her work focuses on improving the understanding and treatment of cancer.

Latest Patents

Zimmerman's latest patents include groundbreaking methods for analyzing immune checkpoint proteins involved in cancer. One of her patents, titled "Immune checkpoint molecular fitness profiling by mass spectrometry," provides material and methods for determining abundance ratios of various immune checkpoint proteins, such as PD-1, PD-L1, and PD-L2, in biospecimen samples. This innovative approach offers an alternative platform for diagnosing and treating cancer, particularly in cases where traditional antibody recognition is ineffective. Another notable patent, "Protein quantitation in multicellular tissue specimens," outlines methods for measuring target protein amounts in heterogeneous multicellular biospecimens containing multiple cell types.

Career Highlights

Lisa J Zimmerman is affiliated with Vanderbilt University, where she continues her research and development in cancer diagnostics. Her work has garnered attention for its potential to revolutionize cancer treatment and improve patient outcomes.

Collaborations

Zimmerman has collaborated with esteemed colleagues, including Daniel C Liebler and Carlos A Morales Betanzos, to advance her research and enhance the impact of her innovations.

Conclusion

Lisa J Zimmerman is a pioneering inventor whose work in cancer diagnostics is shaping the future of medical research. Her patents reflect her commitment to improving cancer treatment through innovative methodologies.

Profile summary based on public USPTO records.